Axis-Shield Settles Homocysteine Patent Dispute

Law360, New York (July 31, 2008, 12:00 AM EDT) -- Medical diagnostics company Axis-Shield ASA has settled a dispute with Diazyme Laboratories, the life sciences division of California-based General Atomics, over patents for enzymatic homocysteine tests.

The Scotland-based company announced Wednesday that it has agreed to withdraw all patent infringement litigation against Diazyme and its partners. In exchange, Diazyme will withdraw opposition to Axis-Shield's homocysteine patents outside the U.S. and license them from Axis-Shield.

The companies’ enzymatic homocysteine assays test whether a person has a high level of the amino acid homocysteine, which could indicate the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.